Invega Sustenna 78 MG per 0.5 ML Extended Release Injectable Suspension in a Prefilled Syringe

RxCUI: 858051
RxNorm name: Invega Sustenna 78 MG per 0.5 ML Extended Release Injectable Suspension in a Prefilled Syringe
Display name: Invega Sustenna 78 MG per 0.5 ML Extended Release Injectable Suspension in a Prefilled Syringe
Full name: Invega Sustenna 78 MG per 0.5 ML Extended Release Injectable Suspension in a Prefilled Syringe
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:49

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
INVEGA SUSTENNA	PALIPERIDONE PALMITATE	Janssen Pharmaceuticals, Inc.	1af14e42-951d-414d-8564-5d5fce138554	2025-02-14	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 858051

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
1af14e42-951d-414d-8564-5d5fce138554	Invega Sustenna 78 MG per 0.5 ML Extended Release Injectable Suspension in a Prefilled Syringe	SY	41	These highlights do not include all the information needed to use INVEGA SUSTENNA safely and effectively. See full prescribing information for INVEGA SUSTENNA. INVEGA SUSTENNA ® (paliperidone palmitate) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2006	20250214
1af14e42-951d-414d-8564-5d5fce138554	0.5 ML paliperidone palmitate 156 MG/ML Prefilled Syringe [Invega]	SBD	41	These highlights do not include all the information needed to use INVEGA SUSTENNA safely and effectively. See full prescribing information for INVEGA SUSTENNA. INVEGA SUSTENNA ® (paliperidone palmitate) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2006	20250214
1af14e42-951d-414d-8564-5d5fce138554	Invega Sustenna 78 MG per 0.5 ML Prefilled Syringe	SY	41	These highlights do not include all the information needed to use INVEGA SUSTENNA safely and effectively. See full prescribing information for INVEGA SUSTENNA. INVEGA SUSTENNA ® (paliperidone palmitate) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2006	20250214
1af14e42-951d-414d-8564-5d5fce138554	0.5 ML Invega Sustenna 156 MG/ML Prefilled Syringe	SY	41	These highlights do not include all the information needed to use INVEGA SUSTENNA safely and effectively. See full prescribing information for INVEGA SUSTENNA. INVEGA SUSTENNA ® (paliperidone palmitate) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2006	20250214
1af14e42-951d-414d-8564-5d5fce138554	Invega Sustenna 78 MG in 0.5 mL Prefilled Syringe	PSN	41	These highlights do not include all the information needed to use INVEGA SUSTENNA safely and effectively. See full prescribing information for INVEGA SUSTENNA. INVEGA SUSTENNA ® (paliperidone palmitate) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2006	20250214